In the early nineties, few years before the birth of Europace, the clinical and scientific world
of familial arrhythmogenic conditions was revolutionized by the identification of the first …

Sudden cardiac death (SCD) is responsible for several millions of deaths every year and
remains a major health problem. To reduce this burden, diagnosing and identification of …

Untreated fresh cardiac tissue is the optimal tissue material for investigating DNA
methylation patterns of cardiac biology and diseases. However, fresh tissue is difficult to …

Aims Reduced psychological health is associated with adverse patient outcomes and higher
mortality. We aimed to examine if a Brugada syndrome (BrS) diagnosis and symptomatic …

Aims To investigate the association of iatrogenic cardiac tamponades as a complication of
invasive electrophysiology procedures (EPs) and mortality as well as serious cardiovascular …

Sudden cardiac death (SCD) is an important public health problem worldwide, accounting
for an estimated 6–20% of total mortality. A significant proportion of SCD is caused by …

This review covers currently available cardiac implantable electronic devices (CIEDs) as
well as updated progress in realtime monitoring techniques for CIEDs. A variety of …

Aims The treatment of atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) can be
challenging since AF aggravates symptoms and increases the risk of stroke. Which factors …

Gene expression of formalin-fixed paraffin-embedded (FFPE) tissue may serve for molecular
studies on cardiovascular diseases. Chemotherapeutics, such as doxorubicin (DOX) may …

Our aim was to determine the prognostic impact of coronary artery disease (CAD) on heart
failure with reduced ejection fraction (HFrEF) mortality and readmissions. From a …